STOCK TITAN

Canopy Growth to Report Q2 2022 Financial Results on November 5, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Canopy Growth Corporation (CGC) will announce its financial results for the second quarter of fiscal year 2022, ending September 30, 2021, on November 5, 2021, before market open. The company's executive team, including CEO David Klein and CFO Mike Lee, will host an audio webcast at 10:00 AM ET on the same day to discuss the results. Canopy Growth, a leading cannabis company, continues to expand its portfolio and market presence, including partnerships with major brands and growth in health and wellness sectors.

Positive
  • None.
Negative
  • None.

SMITHS FALLS, ON, Oct. 22, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2022 ended September 30, 2021, before financial markets open on November 5, 2021.

Following the release of its second quarter fiscal year 2022 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Mike Lee, EVP & CFO at 10:00 AM Eastern Time on November 5, 2021.

Webcast Information

A live audio webcast will be available at:

https://produceredition.webcasts.com/starthere.jsp?ei=1505860&tp_key=a4b00798a9

Replay Information

A replay will be accessible by webcast until 11:59 PM ET on February 3, 2022 at: 

https://produceredition.webcasts.com/starthere.jsp?ei=1505860&tp_key=a4b00798a9

About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp-derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit www.canopygrowth.com.

Notice Regarding Forward Looking Statements
This press release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use

of such terms and phrases as "intend," "goal," "strategy," "estimate," "expect," "project," "projections," "forecasts," "plans," "seeks," "anticipates," "potential," "proposed," "will," "should," "could," "would," "may," "likely," "designed to," "foreseeable future," "believe," "scheduled" and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward–looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward–looking statements and the forward–looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation ("Canopy") can be found under the section entitled "Risk Factors" in Canopy's Annual Report on Form 10-K for the year ended March 31, 2021, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com, respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward–looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward– looking statement. Readers are cautioned not to put undue reliance on any forward–looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/canopy-growth-to-report-q2-2022-financial-results-on-november-5-2021-301406364.html

SOURCE Canopy Growth Corporation

FAQ

When will Canopy Growth report its Q2 2022 financial results?

Canopy Growth will report its Q2 2022 financial results on November 5, 2021.

What time is the Canopy Growth Q2 2022 webcast?

The webcast will take place at 10:00 AM ET on November 5, 2021.

What is the fiscal year end date for Canopy Growth's Q2 2022?

The fiscal year end date for Canopy Growth's Q2 2022 is September 30, 2021.

Where can I access the Canopy Growth Q2 2022 results webcast?

The webcast can be accessed at https://produceredition.webcasts.com/starthere.jsp?ei=1505860&tp_key=a4b00798a9.

Canopy Growth Corporation Common Shares

NASDAQ:CGC

CGC Rankings

CGC Latest News

CGC Stock Data

341.48M
122.34M
0.18%
8.79%
9.58%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
United States of America
SMITH FALLS